Sources: AP
Qatar begins administering the Pfizer–BioNTech COVID-19 vaccine for children aged between 5 to 11 years. It comes after the Ministry of Public Health approves the use of the vaccine for this age group. 2022-01-30
The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group. 2022-01-3
The French Haute Autorité de santé approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years. 2021-12-20
The Medicines and Healthcare Products Regulatory Agency approves booster doses of the Pfizer and AstraZeneca vaccines. 2021-09-9
Ireland opens registration for children between the ages of 12 and 15 to receive a COVID-19 vaccine. Around 280,000 children will be eligible for vaccination with the Pfizer–BioNTech or Moderna vaccines, with more than 50,000 already registered. 2021-08-12
A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective. 2021-06-14
President Iván Duque Márquez receives his first dose of the Pfizer–BioNTech COVID-19 vaccine. 2021-06-13
The European Medicines Agency authorizes the usage of the Pfizer–BioNTech COVID-19 vaccine for people aged 12 to 15 years old, becoming the first vaccine to be approved for children in the European Union. 2021-05-28
Sri Lanka approves the emergency use of the Pfizer–BioNTech COVID-19 vaccine as the country faces its third wave of the pandemic and the highest number of active cases since the pandemic began. The minister overseeing the situation says that Sri Lanka will try to secure five million doses of the vaccine as India has restricted the supply of the Oxford-AstraZeneca COVID-19 vaccine. 2021-05-8